The Technical Analyst
Select Language :
Intersect Ent Inc [XENT]

Exchange: NASDAQ Global Market Sector: Healthcare Industry: Medical Devices

Intersect Ent Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Intersect Ent Inc is listed at the NASDAQ Exchange

0.00% $28.24

Last updated: 16 May 2022 @ 12:23 pm


FUNDAMENTALS
MarketCap: 954.90 mill
EPS: -4.80
P/E: 0.000
Earnings Date: Aug 04, 2022
SharesOutstanding: 33.81 mill
Avg Daily Volume: 0.411 mill
RATING 2022-05-13
B-
Neutral
RATINGDETAILS
Rating CashFlow: Strong Buy
Return On Equity: Strong Buy
Return On Asset: Sell
DE: Sell
P/E: Strong Sell
Price To Book: Strong Sell
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenue
Gr.Profit
Ebit
Asset
Debt
DISCOUNTED CASH FLOW VALUE
$29.39
(4.09%) $1.154
Date: 2022-05-16
True Range Average
+/- $0.182
( +/- 0.64%)
Range: 28.06 - 28.42
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-02-04 West Thomas A. Sell 4 823 Common Stock
2022-02-02 Meier Richard A Sell 2 329 Common Stock
2022-02-02 West Thomas A. Sell 7 763 Common Stock
2022-02-01 Meier Richard A Buy 36 738 Common Stock
2022-02-01 West Thomas A. Buy 106 540 Common Stock
INSIDER POWER
66.32
Last 100 transactions
Buy: 1 489 721 | Sell: 210 420

Forecast: 16:00 - $28.24

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $28.24
Forecast 2: 16:00 - $28.24
Forecast 3: 16:00 - $28.24
SCORE
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $28.24 (0.00% )
Volume 0.000 mill
Avg. Vol. 0.411 mill
% of Avg. Vol 0.000 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Intersect Ent Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Intersect Ent Inc

RSI

Intraday RSI14 chart for Intersect Ent Inc

Last 10 Buy & Sell Signals For XENT

324 Signals | Accuracy: 8.64% | Accuracy Buy: 8.64% | Accuracy Sell: 8.64%

Avg return buy: -0.02 % | Avg return sell: 0.03 %

$1 invested is now $0.96 or -3.61% since 20-04-22

Date Signal @ Closed %
May 12 - 16:01sell$28.24N/AActive
May 12 - 15:57buy$28.25$28.25 @ May 12 - 15:59-0.02%
May 12 - 15:53sell$28.25$28.25 @ May 12 - 15:570.02%
May 12 - 15:49buy$28.25$28.25 @ May 12 - 15:53-0.02%
May 12 - 15:47sell$28.25$28.25 @ May 12 - 15:490.02%
May 12 - 15:45buy$28.25$28.25 @ May 12 - 15:46-0.02%
May 12 - 15:42sell$28.25$28.25 @ May 12 - 15:440.02%
May 12 - 15:38buy$28.25$28.25 @ May 12 - 15:41-0.02%
May 12 - 15:29sell$28.25$28.25 @ May 12 - 15:350.02%
May 12 - 15:27buy$28.25$28.25 @ May 12 - 15:29-0.02%
The Live Chart for Intersect Ent Inc
Profile picture for
            Intersect Ent Inc

XENT

Intersect ENT, Inc., a drug delivery company, researches and develops products for the treatment of patients with ear, nose, and throat conditions in the United States. The company offers PROPEL and PROPEL mini drug releasing implants for patients undergoing sinus surgery to treat chronic sinusitis; and PROPEL Contour, a steroid releasing implant to frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for refractory disease for the treatment of patients in the physician office setting. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was founded in 2003 and is headquartered in Menlo Park, California.

Last 10 Buy Signals
Date Signal @
XELAMay 16 - 12:21$0.324
WIREMay 16 - 12:21$124.66
USAKMay 16 - 12:21$16.99
SKYWMay 16 - 12:21$26.20
SEACMay 16 - 12:21$0.843
RVNCMay 16 - 12:21$14.77
RILYGMay 16 - 12:21$22.94
ROADMay 16 - 12:21$22.36
ONEWMay 16 - 12:21$34.32
OCSLMay 16 - 12:20$7.09

Stock Peers

Company Price Change
XENT28.240.00%
AGEN1.595-2.15%
ATHA8.431.81%
CALT14.565.35%
CLLS3.14-0.95%
CMRX1.745-58.84%
DBVT1.2301.65%
KDNY13.79-1.32%
SPNE8.36-0.12%
VBIV1.0890.83%
ZIOP0.866-0.88%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.